Today, Axiom Space hosted a virtual press conference with the company’s in-space manufacturing and science team, the Saudi Space Commission, and select principal investigators representing the more than 20 different experiments that will be conducted during Axiom Mission 2 (Ax-2).
During the press conference, leaders highlighted the science research, technology demonstrations, and in-space manufacturing projects that will occur on the mission, as well as touched upon Axiom Station and the future of in-space solutions. The speakers included:
Dr. Lucie Low, Chief Scientist, Axiom Space
Jana Stoudemire, Director of In-Space Manufacturing, Axiom Space
Mishaal Ashemimry, Microgravity Research Lead, Saudi Space Agency
Mari Anne Snow, Chief Executive Office, Eascra Biotech
Dr. Clive Svendsen, Executive Director of Regenerative Medicine Institute, Cedars-Sinai
Dr. Catriona Jamieson, Director, Sanford Stem Cell Clinical Center at UC San Diego Health
Dr. Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine
Dava Newman, Director, MIT Media Lab
Ax-2 is now targeted to launch to the International Space Station NET May 8 at 10:43 p.m. EDT aboard a SpaceX Dragon spacecraft from Launch Complex 39A at NASA’s Kennedy Space Center in Florida.